Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development

Accumulating evidence has revealed significant roles for N6-methyladenosine (m 6 A) modification in the development of various cancers. We previously demonstrated an oncogenic role of m 6 A-modified CUB domain containing protein 1 (CDCP1) in bladder cancer (BC) progression. However, the biological f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Xiaoling, Jiang, Xu, Zhang, Haiqing, Liu, Bixia, Huang, Yapeng, Zhu, Xiaowei, Qi, Defeng, Yuan, Gang, Luo, Junhang, Ji, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712571/
https://www.ncbi.nlm.nih.gov/pubmed/33267838
http://dx.doi.org/10.1186/s12943-020-01289-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712571/
https://www.ncbi.nlm.nih.gov/pubmed/33267838
http://dx.doi.org/10.1186/s12943-020-01289-0

Ejemplares similares